{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:16:22Z","timestamp":1765484182539},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T00:00:00Z","timestamp":1585094400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T00:00:00Z","timestamp":1585094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIHR CLAHRC West Midlands","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"NIHR Infrastructure Doctoral Training Exchange Award","award":["IDTE-03016-0#"],"award-info":[{"award-number":["IDTE-03016-0#"]}]},{"name":"NIHR Career Development Fellowship","award":["CDF-2016-09-018"],"award-info":[{"award-number":["CDF-2016-09-018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The database used for the NHS Bowel Cancer Screening Programme (BCSP) derives participant information from primary care records. Combining predictors with FOBTs has shown to improve referral decisions and accuracy. The richer data available from GP databases could be used to complement screening referral decisions by identifying those at greatest risk of colorectal cancer. We determined the availability of data for key predictors and whether this information could be used to inform more accurate screening referral decisions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>An English BCSP cohort was derived using the electronic notifications received from the BCSP database to GP records. The cohort covered a period between 13th May 2009 to 17th January 2017. Completeness of variables and univariable associations were assessed. Risk prediction models were developed using Cox regression and multivariable fractional polynomials with backwards elimination. Optimism adjusted performance metrics were reported. The sensitivity and specificity of a combined approach using the negative FOBT model plus FOBT positive patients was determined using a probability equivalent to a 3% PPV NICE guidelines level.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>292,059 participants aged 60\u201374 were derived for the BCSP screening cohort. A model including the screening test result had a C-statistic of 0.860, c-slope of 0.997, and R<jats:sup>2<\/jats:sup> of 0.597. A model developed for negative screening results only had a C-statistic of 0.597, c-slope of 0.940, and R<jats:sup>2<\/jats:sup> of 0.062. Risk predictors included in the models included; age, sex, alcohol consumption, IBS diagnosis, family history of gastrointestinal cancer, smoking status, previous negatives and whether a GP had ordered a blood test. For the combined screening approach, sensitivity increased slightly from 53.90% (FOBT only) to 58.82% but at the expense of an increased referral rate.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This research has identified several potential predictors for CRC in a BCSP population. A risk prediction model developed for BCSP FOBT negative patients was not clinically useful due to a low sensitivity and increased referral rate. The predictors identified in this study should be investigated in a refined algorithm combining the quantitative FIT result. Combining data from multiple sources enables fuller patient profiles using the primary care and screening database interface.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12876-020-01206-1","type":"journal-article","created":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T08:02:53Z","timestamp":1585123373000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The use of electronic healthcare records for colorectal cancer screening referral decisions and risk prediction model development"],"prefix":"10.1186","volume":"20","author":[{"given":"Jennifer Anne","family":"Cooper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronan","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Stinton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sian","family":"Taylor-Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,25]]},"reference":[{"issue":"6","key":"1206_CR1","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1111\/j.1572-0241.2008.01875.x","volume":"103","author":"P Hewitson","year":"2008","unstructured":"Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008;103(6):1541\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"20","key":"1206_CR2","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.3748\/wjg.v23.i20.3632","volume":"23","author":"M Navarro","year":"2017","unstructured":"Navarro M, Nicolas A, Ferrandez A, Lanas A. Colorectal cancer population screening programs worldwide in 2016: an update. World J Gastroenterol. 2017;23(20):3632\u201342.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"1206_CR3","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1136\/gutjnl-2015-310691","volume":"66","author":"S Moss","year":"2017","unstructured":"Moss S, Mathews C, Day TJ, Smith S, Seaman HE, Snowball J, Halloran SP. Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: results from a pilot study within the national screening programme in England. Gut. 2017;66(9):1631\u201344.","journal-title":"Gut"},{"issue":"1","key":"1206_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/apt.13660","volume":"44","author":"FG Kallenberg","year":"2016","unstructured":"Kallenberg FG, Vleugels JL, de Wijkerslooth TR, Stegeman I, Stoop EM, van Leerdam ME, Kuipers EJ, Bossuyt PM, Dekker E. Adding family history to faecal immunochemical testing increases the detection of advanced neoplasia in a colorectal cancer screening programme. Aliment Pharmacol Ther. 2016;44(1):88\u201396.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"1206_CR5","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.dld.2017.11.002","volume":"50","author":"YS Jung","year":"2018","unstructured":"Jung YS, Park CH, Kim NH, Park JH, Park DI, Sohn CI. A combination of clinical risk stratification and fecal immunochemical test is useful for identifying persons with high priority of early colonoscopy. Dig Liver Dis. 2018;50(3):254\u20139.","journal-title":"Dig Liver Dis"},{"issue":"3","key":"1206_CR6","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1136\/gutjnl-2013-305013","volume":"63","author":"I Stegeman","year":"2014","unstructured":"Stegeman I, de Wijkerslooth TR, Stoop EM, van Leerdam ME, Dekker E, van Ballegooijen M, Kuipers EJ, Fockens P, Kraaijenhagen RA, Bossuyt PM. Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy. Gut. 2014;63(3):466\u201371.","journal-title":"Gut"},{"issue":"2","key":"1206_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/bjc.2017.375","volume":"118","author":"JA Cooper","year":"2018","unstructured":"Cooper JA, Parsons N, Stinton C, Mathews C, Smith S, Halloran SP, Moss S, Taylor-Phillips S. Risk-adjusted colorectal cancer screening using the FIT and routine screening data: development of a risk prediction model. Br J Cancer. 2018;118(2):285\u201393.","journal-title":"Br J Cancer"},{"issue":"5","key":"1206_CR8","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/jamia\/ocv195","volume":"23","author":"Y Kinar","year":"2016","unstructured":"Kinar Y, Kalkstein N, Akiva P, Levin B, Half EE, Goldshtein I, Chodick G, Shalev V. Development and validation of a predictive model for detection of colorectal cancer in primary care by analysis of complete blood counts: a binational retrospective study. J Am Med Inform Assoc. 2016;23(5):879\u201390.","journal-title":"J Am Med Inform Assoc"},{"issue":"1","key":"1206_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cdp.2003.10.002","volume":"28","author":"DW Spell","year":"2004","unstructured":"Spell DW, Jones DV, Harper WF, David Bessman J. The value of a complete blood count in predicting cancer of the colon. Cancer Detect Prev. 2004;28(1):37\u201342.","journal-title":"Cancer Detect Prev"},{"issue":"7","key":"1206_CR10","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/bjc.2017.53","volume":"116","author":"R Goshen","year":"2017","unstructured":"Goshen R, Mizrahi B, Akiva P, Kinar Y, Choman E, Shalev V, Sopik V, Kariv R, Narod SA. Predicting the presence of colon cancer in members of a health maintenance organisation by evaluating analytes from standard laboratory records. Br J Cancer. 2017;116(7):944\u201350.","journal-title":"Br J Cancer"},{"issue":"9","key":"1206_CR11","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1158\/1055-9965.EPI-14-0412","volume":"23","author":"R Shah","year":"2014","unstructured":"Shah R, Jones E, Vidart V, Kuppen PJ, Conti JA, Francis NK. Biomarkers for early detection of colorectal cancer and polyps: systematic review. Cancer Epidemiol Biomark Prevent. 2014;23(9):1712\u201328.","journal-title":"Cancer Epidemiol Biomark Prevent"},{"issue":"1","key":"1206_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/2050640617737004","volume":"6","author":"T Niedermaier","year":"2018","unstructured":"Niedermaier T, Weigl K, Hoffmeister M, Brenner H. Fecal immunochemical tests in combination with blood tests for colorectal cancer and advanced adenoma detection\u2014systematic review. United European Gastroenterol J. 2018;6(1):13\u201321.","journal-title":"United European Gastroenterol J"},{"issue":"9","key":"1206_CR13","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1136\/gut.2010.225987","volume":"60","author":"T Marshall","year":"2011","unstructured":"Marshall T, Lancashire R, Sharp D, Peters TJ, Cheng KK, Hamilton W. The diagnostic performance of scoring systems to identify symptomatic colorectal cancer compared to current referral guidance. Gut. 2011;60(9):1242\u20138.","journal-title":"Gut"},{"key":"1206_CR14","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.1038\/sj.bjc.6605396","volume":"101 l 2","author":"W Hamilton","year":"2009","unstructured":"Hamilton W. The CAPER studies: five case-control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patients. Br J Cancer. 2009;101 l 2:S80\u20136.","journal-title":"Br J Cancer"},{"issue":"594","key":"1206_CR15","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.3399\/bjgp12X616346","volume":"62","author":"J Hippisley-Cox","year":"2012","unstructured":"Hippisley-Cox J, Coupland C. Identifying patients with suspected colorectal cancer in primary care: derivation and validation of an algorithm. Br J Gen Pract. 2012;62(594):e29\u201337.","journal-title":"Br J Gen Pract"},{"key":"1206_CR16","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/bjc.2012.266","volume":"107","author":"GS Collins","year":"2012","unstructured":"Collins GS, Altman DG. Identifying patients with undetected colorectal cancer: an independent validation of QCancer (colorectal). Br J Cancer. 2012;107:260.","journal-title":"Br J Cancer"},{"key":"1206_CR17","doi-asserted-by":"crossref","unstructured":"Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, S\u00f8rensen HT, von Elm E, Langan SM, Committee RW. The REporting of studies conducted using observational routinely-collected health data (RECORD) statement. PLoS Med. 2015;12(10):\u2013e1001885.","DOI":"10.1371\/journal.pmed.1001885"},{"issue":"1","key":"1206_CR18","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M14-0698","volume":"162","author":"KG Moons","year":"2015","unstructured":"Moons KG, Altman DG, Reitsma JB, Ioannidis JP, Macaskill P, Steyerberg EW, Vickers AJ, Ransohoff DF, Collins GS. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162(1):W1\u201373.","journal-title":"Ann Intern Med"},{"key":"1206_CR19","unstructured":"THIN-HES Privacy Notice. https:\/\/www.iqvia.com\/locations\/united-kingdom\/information-for-members-of-the-public\/thin-hes-data. Accessed 1 Feb 2020."},{"issue":"1","key":"1206_CR20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/pds.1688","volume":"18","author":"A Maguire","year":"2009","unstructured":"Maguire A, Blak BT, Thompson M. The importance of defining periods of complete mortality reporting for research using automated data from primary care. Pharmacoepidemiol Drug Saf. 2009;18(1):76\u201383.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1206_CR21","unstructured":"National Institute for Health and Care Excellence: Suspected cancer: recognition and referral [NICE guidelines NG12]. In.; June 2015."},{"issue":"1","key":"1206_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1741-7015-7-17","volume":"7","author":"W Hamilton","year":"2009","unstructured":"Hamilton W, Lancashire R, Sharp D, Peters T, Cheng K, Marshall T. The risk of colorectal cancer with symptoms at different ages and between the sexes: a case-control study. BMC Med. 2009;7(1):17.","journal-title":"BMC Med"},{"key":"1206_CR23","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/sj.bjc.6602714","volume":"93","author":"W Hamilton","year":"2005","unstructured":"Hamilton W, Round A, Sharp D, Peters T. Clinical features of colorectal cancer before diagnosis: a population-based case-control study. Br J Cancer. 2005;93:399\u2013405.","journal-title":"Br J Cancer"},{"key":"1206_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12876-016-0475-7","volume":"16","author":"TGS Williams","year":"2016","unstructured":"Williams TGS, Cubiella J, Griffin SJ, Walter FM, Usher-Smith JA. Risk prediction models for colorectal cancer in people with symptoms: a systematic review. BMC Gastroenterol. 2016;16:63.","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"1206_CR25","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M14-0698","volume":"162","author":"KM Moons","year":"2015","unstructured":"Moons KM, Altman DG, Reitsma JB, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (tripod): explanation and elaboration. Ann Intern Med. 2015;162(1):W1\u2013W73.","journal-title":"Ann Intern Med"},{"issue":"4","key":"1206_CR26","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/bjs.4879","volume":"92","author":"S Ahmed","year":"2005","unstructured":"Ahmed S, Leslie A, Thaha MA, Carey FA, Steele RJ. Lower gastrointestinal symptoms are not predictive of colorectal neoplasia in a faecal occult blood screen-positive population. Br J Surg. 2005;92(4):478\u201381.","journal-title":"Br J Surg"},{"issue":"2","key":"1206_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/0036933013482638","volume":"58","author":"JD Saldanha","year":"2013","unstructured":"Saldanha JD, Moug SJ, Linton K, Diament RH. Symptoms do not predict colorectal cancer in an FOB screened population. Scott Med J. 2013;58(2):95\u20138.","journal-title":"Scott Med J"},{"issue":"3","key":"1206_CR28","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1177\/2050640617733922","volume":"6","author":"CM de Klerk","year":"2018","unstructured":"de Klerk CM, van der Vlugt M, Bossuyt PM, Dekker E. A large proportion of fecal immunochemical test-positive participants in colorectal cancer screening is symptomatic. United European Gastroenterol J. 2018;6(3):471\u20139.","journal-title":"United European Gastroenterol J"},{"issue":"563","key":"1206_CR29","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3399\/bjgp09X420860","volume":"59","author":"W Hamilton","year":"2009","unstructured":"Hamilton W. Five misconceptions in cancer diagnosis. Br J Gen Pract. 2009;59(563):441\u20136.","journal-title":"Br J Gen Pract"},{"key":"1206_CR30","doi-asserted-by":"crossref","unstructured":"Riley RD, Snell KIE, Moons KGM, Debray T, P.A. Fundamental statistical methods for prognosis research. In: Prognosis Research in Healthcare: Concepts, Methods and Impact. Edn. Edited by Riley RD, van der Windt DA, Croft P, Moons KGM. New York, United States of America: Oxford University Press; 2019.","DOI":"10.1093\/med\/9780198796619.003.0004"},{"issue":"12","key":"1206_CR31","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1016\/j.csda.2005.07.015","volume":"50","author":"W Sauerbrei","year":"2006","unstructured":"Sauerbrei W, Meier-Hirmer C, Benner A, Royston P. Multivariable regression model building by using fractional polynomials: description of SAS, STATA and R programs. Comput Stat Data Anal. 2006;50(12):3464\u201385.","journal-title":"Comput Stat Data Anal"},{"key":"1206_CR32","unstructured":"mfp \u2014 Multivariable fractional polynomial models. https:\/\/www.stata.com\/manuals13\/rmfp.pdf. Accessed 1 Feb 2020."},{"key":"1206_CR33","unstructured":"Cleves M, Gould W, Marchenko YV. An introduction to survival analysis using Stata, revised third edition edn. Texas, USA: Stata Press; 2016."},{"issue":"5","key":"1206_CR34","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/sim.4780090503","volume":"9","author":"EL Korn","year":"1990","unstructured":"Korn EL, Simon R. Measures of explained variation for survival data. Stat Med. 1990;9(5):487\u2013503.","journal-title":"Stat Med"},{"issue":"11","key":"1206_CR35","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/sim.4780091109","volume":"9","author":"JC Van Houwelingen","year":"1990","unstructured":"Van Houwelingen JC, Le Cessie S. Predictive value of statistical models. Stat Med. 1990;9(11):1303\u201325.","journal-title":"Stat Med"},{"issue":"9","key":"1206_CR36","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1097\/MEG.0000000000000160","volume":"26","author":"R Launois","year":"2014","unstructured":"Launois R, Le Moine JG, Uzzan B, Fiestas Navarrete LI, Benamouzig R. Systematic review and bivariate\/HSROC random-effect meta-analysis of immunochemical and guaiac-based fecal occult blood tests for colorectal cancer screening. Eur J Gastroenterol Hepatol. 2014;26(9):978\u201389.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"1206_CR37","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1586\/17474124.2013.811045","volume":"7","author":"CJ Rees","year":"2013","unstructured":"Rees CJ, Bevan R. The National Health Service Bowel Cancer Screening Program: the early years. Expert Rev Gastroenterol Hepatol. 2013;7(5):421\u201337.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"1206_CR38","doi-asserted-by":"crossref","unstructured":"Pham TM, Carpenter JR, Morris TP, Wood AM, Petersen I. Population-calibrated multiple imputation for a binary\/categorical covariate in categorical regression models. Stat Med. 2019;38(5):792\u2013808.","DOI":"10.1002\/sim.8004"},{"issue":"7","key":"1206_CR39","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1007\/s10620-016-4081-x","volume":"61","author":"B Boursi","year":"2016","unstructured":"Boursi B, Mamtani R, Hwang WT, Haynes K, Yang YX. A risk prediction model for sporadic CRC based on routine lab results. Dig Dis Sci. 2016;61(7):2076\u201386.","journal-title":"Dig Dis Sci"},{"issue":"10","key":"1206_CR40","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1002\/cam4.1183","volume":"6","author":"J Birks","year":"2017","unstructured":"Birks J, Bankhead C, Holt TA, Fuller A, Patnick J. Evaluation of a prediction model for colorectal cancer: retrospective analysis of 2.5 million patient records. Cancer Med. 2017;6(10):2453\u201360.","journal-title":"Cancer Med"},{"issue":"6","key":"1206_CR41","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/pds.1934","volume":"19","author":"L Marston","year":"2010","unstructured":"Marston L, Carpenter JR, Walters KR, Morris RW, Nazareth I, Petersen I. Issues in multiple imputation of missing data for large general practice clinical databases. Pharmacoepidemiol Drug Saf. 2010;19(6):618\u201326.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1206_CR42","doi-asserted-by":"crossref","unstructured":"Digby J, Fraser CG, Carey FA, Diament RH, Balsitis M, Steele RJ. Faecal haemoglobin concentration is related to detection of advanced colorectal neoplasia in the next screening round. Journal of medical screening 2016.","DOI":"10.1177\/0969141316653983"},{"key":"1206_CR43","doi-asserted-by":"crossref","unstructured":"Li W, Zhao L-Z, Ma D-W, Wang D-Z, Shi L, Wang H-L, Dong M, Zhang S-Y, Cao L, Zhang W-H et al: Predicting the risk for colorectal cancer with personal characteristics and fecal immunochemical test 2018, 97(18):e0529.","DOI":"10.1097\/MD.0000000000010529"},{"key":"1206_CR44","doi-asserted-by":"publisher","first-page":"105746","DOI":"10.1016\/j.ypmed.2019.06.004","volume":"126","author":"W van de Veerdonk","year":"2019","unstructured":"van de Veerdonk W, Hoeck S, Peeters M, Van Hal G. Towards risk-stratified colorectal cancer screening. Adding risk factors to the fecal immunochemical test: Evidence, evolution and expectations. Prev Med. 2019;126:105746.","journal-title":"Prev Med"},{"issue":"3","key":"1206_CR45","doi-asserted-by":"publisher","first-page":"e10191","DOI":"10.1002\/lrh2.10191","volume":"3","author":"E Ford","year":"2019","unstructured":"Ford E, Boyd A, Bowles JKF, Havard A, Aldridge RW, Curcin V, Greiver M, Harron K, Katikireddi V, Rodgers SE, et al. Our data, our society, our health: a vision for inclusive and transparent health data science in the United Kingdom and beyond. Learn Health Syst. 2019;3(3):e10191.","journal-title":"Learn Health Syst"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-020-01206-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12876-020-01206-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-020-01206-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T00:09:35Z","timestamp":1616630975000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-020-01206-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,25]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1206"],"URL":"https:\/\/doi.org\/10.1186\/s12876-020-01206-1","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,25]]},"assertion":[{"value":"27 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The NHS South-East Multi-centre Research Ethics Committee (MREC) approved The Health Improvement Network (THIN) data collection in 2003. An Independent Scientific Review Committee (SRC) administered by IQVIA (formerly IMS Health) reviews and approves protocols for the use of the database and informs the relevant Ethics committee. The SRC approved the use of the THIN database for this study (SRC Reference Number: 16THIN037 Date: 26\/05\/2016).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}